CDK4/6 inhibitor resistance confers collateral paclitaxel hypersensitivity in luminal breast cancer
收藏官方服务：
资源简介：
Processed data supporting "CDK4/6 inhibitor resistance confers collateral paclitaxel hypersensitivity in luminal breast cancer". Contains combined raw counts and normalized counts (MCF7 parental vs palbociclib-resistant, DMSO vs paclitaxel 50 nM 12 h, 3 biological replicates per group), annotated differential expression results for the four relevant comparisons (DESeq2), GSEA Hallmark enrichment results, and metabolomics quantification plus differential metabolite tables (NEG/POS modes). Raw RNA-seq FASTQ files will be deposited in GEO (accession pending).
提供机构：
Zenodo创建时间：
2026-08-13
